Wisit Prasithsirikul

1.9k citations

54 papers · 997 indexed · h-index 23

Virology top 2%
- HIV Research and Treatment 26
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 29
- HIV/AIDS Research and Interventions 15
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 5
Emergency Medicine top 2%
- HIV-related health complications and treatments 18
Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment 7
Modeling and Simulation top 10%
- COVID-19 epidemiological studies 4

Co-authors: Kiat Ruxrungtham Somnuek Sungkanuparph Weerawat Manosuthi Sirirat Likanonsakul Wannarat Pongpirul Jintanat Ananworanich Krit Pongpirul Sumonmal Uttayamakul
Cited by: Virology Infectious Diseases Emergency Medicine
Partner nations: Thailand United States Switzerland

In The Last Decade

Wisit Prasithsirikul

53 papers receiving 969 citations

Peers

Countries citing papers authored by Wisit Prasithsirikul

Since Specialization

Citations

This map shows the geographic impact of Wisit Prasithsirikul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wisit Prasithsirikul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wisit Prasithsirikul more than expected).

Fields of papers citing papers by Wisit Prasithsirikul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wisit Prasithsirikul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wisit Prasithsirikul. The network helps show where Wisit Prasithsirikul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wisit Prasithsirikul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wisit Prasithsirikul Line = papers co-authored together Wisit Prasithsirikul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection Pajaree Chariyavilaskul,Nantaporn Prompila,Supeecha Wittayalertpanya,Sookruethai Lekhyananda,Wisit Prasithsirikul,Thananda Trakarnvanich,Somboon Jeenapongsa,Paweena Susantitaphong,Stephen Kerr,Anchalee Avihingsanon,Pisit Tangkijvanich,Kearkiat Praditpornsilpa	2024	1
2	Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen Supitchaya Phirom,Jeerath Phannajit,Watsamon Jantarabenjakul,Leilani Paitoonpong,Thidarat Kitrungphaiboon,Nuchjarnun Choktaweesak,Pawinee Kupatawintu,Salin Wattanatorn,Wisit Prasithsirikul,Somchai Eiam‐Ong,Yingyos Avihingsanon,Pokrath Hansasuta,Jakapat Vanichanan,Natavudh Townamchai	2022	1
3	ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis Wisit Prasithsirikul,Tanawin Nopsopon,Phanupong Phutrakool,Pawita Suwanwattana,Piyawat Kantagowit,Wannarat Pongpirul,Anan Jongkaewwattana,Krit Pongpirul	2022	3
4	Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study Athiphat Banjongjit,Supitchaya Phirom,Jeerath Phannajit,Watsamon Jantarabenjakul,Leilani Paitoonpong,Wonngarm Kittanamongkolchai,Salin Wattanatorn,Wisit Prasithsirikul,Somchai Eiam‐Ong,Yingyos Avihingsanon,Pokrath Hansasuta,Jakapat Vanichanan,Natavudh Townamchai	2022	2
5	Multiple clades of SARS‐CoV‐2 were introduced to Thailand during the first quarter of 2020 Rome Buathong,Walairat Chaifoo,Sopon Iamsirithaworn,Supaporn Wacharapluesadee,Yutthana Joyjinda,Apaporn Rodpan,Weenassarin Ampoot,Opass Putcharoen,Leilani Paitoonpong,Gompol Suwanpimolkul,Watsamon Jantarabenjakul,Sininat Petcharat,Saowalak Bunprakob,Siriporn Ghai,Wisit Prasithsirikul,Anek Mungaomklang,Tanarak Plipat,Thiravat Hemachudha	2021	5
6	Potential dual dengue and SARS-CoV-2 infection in Thailand: A case study Anuttra C. Ratnarathon,Krit Pongpirul,Wannarat Pongpirul,Lantharita Charoenpong,Wisit Prasithsirikul	2020	24
7	A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection Sirirat Likanonsakul,Bussakorn Suntisuklappon,Ravee Nitiyanontakij,Wisit Prasithsirikul,Emi E. Nakayama,Tatsuo Shioda,Chariya Sangsajja	2016	28
8	Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand Wisit Prasithsirikul,Sukanya Chongthawonsatid,Pirapon June Ohata,Siriwan Keadpudsa,Virat Klinbuayaem,Patsamon Rerksirikul,Stephen J. Kerr,Kiat Ruxrungtham,Jintanat Ananworanich,Anchalee Avihingsanon,(unknown)	2016	28
9	Prevalence of Metabolic Syndrome Among Antiretroviral-Naive and Antiretroviral-Experienced HIV-1 Infected Thai Adults Jureeporn Jantarapakde,Nittaya Phanuphak,Chintana Chaturawit,Supabhorn Pengnonyang,Pornpen Mathajittiphan,Piyaporn Takamtha,Narunat Dungjun,Suteeraporn Pinyakorn,Warabhorn Pima,Wisit Prasithsirikul,Praphan Phanuphak	2014	55
10	Risk of First-line Antiretroviral Therapy Failure in HIV-infected Thai Children and Adolescents Torsak Bunupuradah,Sirintip Sricharoenchai,Rawiwan Hansudewechakul,Virat Klinbuayaem,Sirinya Teeraananchai,Orasri Wittawatmongkol,Noppadon Akarathum,Wisit Prasithsirikul,Jintanat Ananworanich	2014	14
11	Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database Wanatpreeya Phongsamart,Rawiwan Hansudewechakul,Torsak Bunupuradah,Virat Klinbuayaem,Sirinya Teeraananchai,Wisit Prasithsirikul,Stephen J. Kerr,Noppadon Akarathum,Sukanda Denjunta,Jintanat Ananworanich,Kulkanya Chokephaibulkit	2014	22
12	Polymorphisms in Fas Gene Is Associated with HIV-Related Lipoatrophy in Thai Patients Sirirat Likanonsakul,Tippawan Rattanatham,Siriluk Feangvad,Sumonmal Uttayamakul,Wisit Prasithsirikul,Somkid Srisopha,Ravee Nitiyanontakij,Pimrapat Tengtrakulcharoen,Maciej Tarkowski,Agostino Riva,Emi E. Nakayama,Tatsuo Shioda	2012	9
13	A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study Torsak Bunupuradah,Ploenchan Chetchotisakd,Jintanat Ananworanich,Warangkana Munsakul,Supunnee Jirajariyavej,Pacharee Kantipong,Wisit Prasithsirikul,Somnuek Sungkanuparph,Chureeratana Bowonwatanuwong,Virat Klinbuayaem,Stephen J. Kerr,Jiratchaya Sophonphan,Sorakij Bhakeecheep,Bernard Hirschel,Kiat Ruxrungtham,(unknown)	2012	35
14	Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting Krittaecho Siripassorn,Weerawat Manosuthi,Suthat Chottanapund,Aranya Pakdee,Siriwan Sabaitae,Wisit Prasithsirikul,Preecha Tunthanathip,Kiat Ruxrungtham	2010	10
15	Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens Weerawat Manosuthi,Wiroj Mankatitham,Aroon Lueangniyomkul,Wisit Prasithsirikul,Preecha Tantanathip,Busakorn Suntisuklappon,Anongnuch Narkksoksung,Samruay Nilkamhang,Somnuek Sungkanuparph	2010	10
16	Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure Weerawat Manosuthi,Sasisopin Kiertiburanakul,Wannarat Amornnimit,Wisit Prasithsirikul,Supeda Thongyen,Samruay Nilkamhang,Kiat Ruxrungtham,Somnuek Sungkanuparph	2009	8
17	Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study Weerawat Manosuthi,Somnuek Sungkanuparph,Somsit Tansuphaswadikul,Wisit Prasithsirikul,Chatiya Athichathanabadi,Sirirat Likanonsakul,Achara Chaovavanich	2008	1
18	Health Utilities in Patients with HIV/AIDS in Thailand Phantipa Sakthong,Jon C. Schommer,Cynthia R. Gross,Wisit Prasithsirikul,Rungpetch Sakulbumrungsil	2008	22
19	Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting Weerawat Manosuthi,Wisit Prasithsirikul,Noppanath Chumpathat,Bussakorn Suntisuklappon,Chatiya Athichathanabadi,Sukanya Chimsuntorn,Somnuek Sungkanuparph	2008	11
20	Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin Weerawat Manosuthi,Somnuek Sungkanuparph,Ammarin Thakkinstian,Asda Vibhagool,Sasisopin Kiertiburanakul,Sasivimol Rattanasiri,Wisit Prasithsirikul,Jongkol Sankote,Apicha Mahanontharit,Kiat Ruxrungtham	2005	62

About Wisit Prasithsirikul

Wisit Prasithsirikul is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 54 papers that have together received 997 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (26 papers), HIV-related health complications and treatments (18 papers), HIV/AIDS Research and Interventions (15 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), COVID-19 Clinical Research Studies (5 papers) and COVID-19 epidemiological studies (4 papers). The work is most often cited by research in Virology (331 citations), Infectious Diseases (730 citations) and Emergency Medicine (238 citations). Wisit Prasithsirikul has collaborated with scholars based in Thailand, United States and Switzerland. Frequent co-authors include Kiat Ruxrungtham, Somnuek Sungkanuparph, Weerawat Manosuthi, Sirirat Likanonsakul, Wannarat Pongpirul, Jintanat Ananworanich, Krit Pongpirul, Sumonmal Uttayamakul, Bernard Hirschel and Ploenchan Chetchotisakd.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact